In this video, Dr. Scott Kuhns (Amgen, Process Development, Director) explains how genomic variants can lead to different outcomes in patients following the same pharmaceutical regimen. Dr. Kuhns also describes what personalized prescriptions are, and how personalized prescriptions can lead to the same desired therapeutic outcome across individuals having different genotypes, particularly in the case of codeine metabolism.